✦ LIBER ✦

Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

✍ Scribed by Iglarz, M.; Binkert, C.; Morrison, K.; Fischli, W.; Gatfield, J.; Treiber, A.; Weller, T.; Bolli, M. H.; Boss, C.; Buchmann, S.; Capeleto, B.; Hess, P.; Qiu, C.; Clozel, M.

Book ID: 124069069
Publisher: American Society for Pharmacology and Experimental Therapeutics
Year: 2008
Tongue: English
Weight: 255 KB
Volume: 327
Category: Article
ISSN: 0022-3565
DOI: 10.1124/jpet.108.142976

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Cyclosporine and Rifampin on t

Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist

✍ Shirin Bruderer; Päivi Äänismaa; Marie-Claude Homery; Stephanie Häusler; Kyle La 📂 Article 📅 2011 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 479 KB

Pharmacology of an active metabolite of

Pharmacology of an active metabolite of DuP 753 — an orally-active nonpeptide angiotensin II receptor antagonist

✍ P.B.M.W.M. Timmermans; P.C. Wong; W.A. Price; A.T. Chiu; J.V. Duncia; D.J. Carin 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 93 KB

The Discovery of N -[5-(4-Bromophenyl)-6

The Discovery of N -[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]- N ′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist

✍ Bolli, Martin H.; Boss, Christoph; Binkert, Christoph; Buchmann, Stephan; Bur, D 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 607 KB

Pharmacological characterization of YM59

Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ETA receptor antagonist

✍ Hironori Yuyama; Masanao Sanagi; Akiko Koakutsu; Mikiko Mori; Akira Fujimori; Hi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 852 KB

The pharmacology of LY290324 in the guin

The pharmacology of LY290324 in the guinea-pig: an orally active, potent and selective cysteinyl leukotriene receptor antagonist

✍ John R. Boot; Ann Bond; Kathy H. Thomas; Annabel O'Brien; Jeremy Gilmore; Alex T 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 608 KB

Safety and efficacy of an orally active

Safety and efficacy of an orally active selective endothelin—A receptor antagonist in moderate-severe human chronic heart failure

✍ Horng H. Chen; Lisa M. Salz; Linda J. McKinley; Lyle J. Olson; Daniel D. Borgeso 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 125 KB